Subutex and Suboxone are not the same medication, though they share the same primary active ingredient: buprenorphine. Both are used to treat opioid use disorder, but Suboxone contains a second ingredient, naloxone, that Subutex does not. That single difference shapes how each medication works, who it’s prescribed to, and how much it costs.
The Key Ingredient Difference
Subutex contains only buprenorphine, a partial opioid agonist that attaches to the same receptors in the brain that opioids target. It reduces cravings and withdrawal symptoms without producing the intense high of full opioids like heroin or oxycodone. Buprenorphine also has a built-in safety feature: a ceiling effect on respiratory depression. In studies of healthy volunteers, doubling the dose of buprenorphine did not meaningfully increase respiratory depression, which makes overdose less likely compared to full opioids.
Suboxone contains that same buprenorphine plus naloxone, an opioid blocker. The standard Suboxone sublingual film comes in two strengths: 2 mg buprenorphine with 0.5 mg naloxone, and 8 mg buprenorphine with 2 mg naloxone. The ratio is always 4:1.
Why Naloxone Is Added
Naloxone was added to Suboxone specifically to discourage misuse by injection. Here’s why that works: when you dissolve a Suboxone film under your tongue as directed, naloxone has very low bioavailability. It barely gets absorbed and has little to no effect on how the buprenorphine works. You get the full therapeutic benefit.
If someone dissolves the film and injects it instead, the naloxone becomes fully active in the bloodstream. It blocks buprenorphine’s effects and can trigger acute withdrawal symptoms in someone who is physically dependent on opioids. This makes injecting Suboxone a deeply unpleasant experience, which serves as a strong deterrent. Subutex, containing only buprenorphine, lacks this safeguard.
Who Gets Subutex Instead of Suboxone
Because Suboxone has that added misuse deterrent, it’s the more commonly prescribed of the two for most patients with opioid use disorder. Subutex (or its generic equivalent, plain buprenorphine) is typically reserved for specific situations.
Pregnancy is the most common reason. Most experts recommend buprenorphine alone for pregnant patients because fewer studies have evaluated the combination product during pregnancy. Interestingly, a meta-analysis found that babies born to mothers who received the combination (buprenorphine plus naloxone) were actually less likely to need treatment for neonatal withdrawal than those whose mothers received other opioid medications. Still, the standard clinical guidance leans toward the mono product during pregnancy.
Some patients also receive buprenorphine alone if they have a documented sensitivity or allergic reaction to naloxone, though this is uncommon.
Brand-Name Subutex No Longer Exists
One detail that often causes confusion: brand-name Subutex tablets were discontinued from the U.S. market. The FDA confirmed this was not for safety or effectiveness reasons. Generic buprenorphine sublingual tablets remain available and are the functional equivalent. So when people refer to “Subutex” today, they typically mean generic buprenorphine tablets.
Suboxone, by contrast, is still available as a brand-name sublingual film, though generic versions of the buprenorphine/naloxone combination also exist in both tablet and film form.
Cost Differences
The price gap between the two can be significant. Without insurance, generic buprenorphine tablets (the Subutex equivalent) run roughly $0.86 to $1.14 per 8 mg tablet, putting a 30-day supply at about $26 to $34. Brand-name Suboxone film costs considerably more, around $5.16 per unit, or roughly $155 for 30 films at the lowest strength. Generic versions of the combination product fall somewhere in between, but plain buprenorphine tablets are consistently the least expensive option.
Insurance coverage varies widely. Many plans and state Medicaid programs cover one formulation but not the other, or require prior authorization for the brand-name product. If cost is a concern, generic buprenorphine tablets are often the most accessible option, though your prescriber’s recommendation will depend on your clinical situation.
Side Effects and Daily Experience
Because buprenorphine is the active therapeutic ingredient in both medications, the core side effect profile is similar. Common effects include headache, nausea, constipation, sweating, and insomnia. These tend to be most noticeable in the first few days or weeks and often improve as your body adjusts.
When taken as directed under the tongue, the naloxone in Suboxone does not typically add its own side effects. It’s essentially inactive at that point. The only scenario where the naloxone component creates problems is if the medication is injected, which triggers withdrawal symptoms: muscle aches, anxiety, vomiting, rapid heartbeat, and intense discomfort. This is by design, not a flaw.
Effectiveness Is Comparable
Both medications are equally effective at managing opioid cravings and withdrawal symptoms when taken as prescribed. The buprenorphine does the therapeutic work in both cases, and since naloxone is barely absorbed sublingually, it doesn’t reduce Suboxone’s effectiveness. The choice between them comes down to clinical context (such as pregnancy), cost, and the prescriber’s assessment of misuse risk, not a difference in how well they treat opioid dependence.
For most people starting treatment, the combination product is the default recommendation because of its added safety margin. If you’re currently taking one and wondering whether the other would work better for you, the switch is straightforward in either direction, though it should always be managed by your prescriber to ensure the right dosing and timing.